CIDRAP newsletters options
A series of papers yesterday in Infection Control and Hospital Epidemiology by researchers and clinicians with the Veterans Health Administration (VHA) identifies key knowledge gaps and lays out research agendas to address the spread of drug-resistant pathogens in healthcare settings.
Increased antibiotic use alters the human microbiome, Martin Blaser says.
Cases are now at 353, an increase of 140 cases from the previous week.
Bavarian Nordic today announced promising findings for a phase 3 study of its smallpox vaccine Imvamune, which compared its efficacy against ACAM200, the smallpox vaccine currently licensed in the United States. Imvamune is a nonreplicating vaccine designed to be safer for use in patients who shouldn't be given the replicating vaccine, such as those with atopic dermatitis or HIV.
A longitudinal study in Papua New Guinea has found that mass administration of antibiotics followed by targeted treatment did not eliminate yaws, researchers reported yesterday in The Lancet. The study also discovered the first signs of resistance in the tropical infection, which causes chronic disfiguring skin ulcers in children in at least 14 countries.
Half of EU nations report that only a third of older adults are vaccinated against flu.
A UK outbreak involves swans from a flock owned by Queen Elizabeth at Windsor.
In a joint statement today the World Health Organization (WHO) and South Korean health officials issued public health recommendations for people attending the upcoming winter Olympic and Paralympic Games in Pyeongchang.
An online survey of frontline prescribers found mostly positive attitudes toward antimicrobial stewardship programs (ASPs) but also identified several specific deficiencies related to knowledge, prescribing practices, and awareness of available resources, according to a study yesterday in Infection Control and Hospital Epidemiology.
Since July 2012, the FDA has approved 12 products that are now on the market.
Flu activity is still high in the Northern Hemisphere's temperate-zone countries, with a few countries now reporting hospitalization and intensive care unit admission levels that top previous seasons, the World Health Organization (WHO) said yesterday in its latest global flu update. Adults ages 65 and older are the hardest hit groups in both Canada and the United States.
The Infectious Diseases Society of America (IDSA) today released a letter urging Congress to provide new economic incentives for the development of new antimicrobial drugs.
One study hints that infection in children and young adults may affect brain health.
The findings undermine the country's efforts to combat rising antibiotic resistance.
Today the French pharmaceutical company, Sanofi Pasteur, said they would not pay the Philippines millions of dollars in return for Dengvaxia vaccines, after the country halted a national vaccination program in light of concerns the vaccine can cause severe infection in dengue-immune recipients.
The United States, Brazil, Argentina, and now Canada, have all reported cases of cephalosporin-resistant gonorrhea, according to the latest situation report published by the Pan American Health organization (PAHO).
Strains with key drug-resistance genes grew from 16% of samples in 2008 to 68% in 2013.
By every metric, this H3N2-dominated season is measuring up as a bad one.
Allergan, a pharmaceutical company based in Dublin, Ireland, yesterday announced that the US Food and Drug Administration (FDA) has approved an expanded indication for its antibiotic combination drug Avycaz (ceftazidime and avibactam) to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by gram-negative organisms.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
